First Sense Medical

Our Product

Product Overview

FirstSense Medical is developing a revolutionary automated tester for breast cancer screening. First Sense Breast Exam® will generate no radiation. FirstSense Breast Exam® uses Advanced Thermal Profiling (ATP).

The FirstSense testers:

  • Reduce the cost of testing dramatically.
  • Reduce human error and variability in judgment of clinical breast exams with the consistency and objectivity of robotics and computer software.
  • Utilize patient questionnaire and test input data onsite, provide immediate results to the doctor and compare results to prior tests for very early detection.
  • Send test data and results via the internet for (a) backup; (b) correlation with subsequent diagnostic testing, including biopsies; (c) comparison to results from other patients with similar profiles; and (d) refinement of the tester’s algorithms.

Product Advantages:

  • Higher sensitivity can save lives. FirstSense Medical’s projected sensitivity (ability to detect cancer) is 95% vs. CBE’s 44%. More than half of the time Clinical Breast Exam's (CBE) miss cancer, allowing it to grow or spread throughout the body, which can lead to death. People do not die from breast cancer, they die from breast cancer spreading to vital organs.
  • Earlier detection provides less opportunity for cancer to spread resulting in fewer invasive surgeries and deaths. FirstSense Medical® projected sensitivity is much higher (95% at one centimeter) vs. CBE (44% at ~ two centimeters). Earlier detection may result in lumpectomy vs. mastectomy, saving part of the breast, reducing emotional trauma and reducing cost. Detection of smaller lesions with less mass reduces the likelihood the cancer will spread. 
    FirstSense Medical® will detect tumors with 8 times less mass than CBE.
  • Automatic year-to-year test comparison allows for very early detection. In some cases, the lesion can be detected at ~ ½ centimeter because the system will detect heat from blood vessels that feed the tumor or small changes from year to year. 
  • More comfortable and less embarrassing. Some women find manual palpation to be uncomfortable and/or embarrassing. Some cultures or religious groups forbid women from exposing their breasts to a male doctor. The FirstSense Medical Breast Exam® allows for automated testing with patient privacy.
  • Broader age range. The FirstSense Medical® testers will be used to screen women for breast cancer at any age with 95% sensitivity. For women under age 40, CBE sensitivity is lower than 44% due to higher breast density because the FirstSense Medical Breast Exam® generates no harmful or accumulated radiation, patients will be able to be scanned more frequently with no fear of the harmful effects of radiation.
  • Backup over the Internet. FirstSense Medical’s system will allow input of biopsy data, compares data nationally, updates the algorithms and provides for updates to the tester for continual improvement.